CryoLife raises FY15 EPS to 0c from (3c)-0c, consensus 0c Cuts FY15 revenue to $148.5M-$150.5M from $151M-$153M, consensus $149.85M. Backs FY15 mid-single digits % increase in product revenues. Backs FY15 low-single digits % increase in tissue processing revenue. Backs FY15 gross margins to be approximately 60%. Backs FY15 R&D expenses to be $13M-$14M.